Founder & CEO buy adds $570k to Retractable Technologies stake

Retractable Technologies‘ (NYSE:RVP) founder & CEO, Thomas Shaw, bought 1 million shares of common stock in the company at 57¢ apiece, according to a regulatory filing. The move comes just days after a federal appeals court ruled that Becton Dickinson & Co. (NYSE:BDX) owes nothing in a case brought by the Little Elm, Texas-based company. Get the full story

Becton Dickinson to acquire Bard in $24B deal

Becton Dickinson (NYSE:BDX) has inked an agreement with C. R. Bard (NYSE:BCR) to acquire the medtech company for $317.00 per Bard common share in cash and stock, valuing the deal at $24 billion. In announcing the deal yesterday, Franklin Lakes, N.J.-based BD said it plans to create a new segment within the company, BD Interventional, to

DoD taps BD’s Pyxis for $100m medication dispensing contract

Becton Dickinson & Co. (NYSE:BDX) said today that it won a $100 million contract from the U.S. Department of Defense for its Pyxis ES system. According to the contract, Franklin Lakes, N.J.-based BD will provide its medication dispensing technology to 115 military inpatient health facilities and military inpatient pharmacies. Get the full story at our sister